Ajaykumar Vishwakarma, MS, BDS, MBA

Founder and CEO of Cell Bioengines LLC
Biography

Mentor: Ali Salem, PhD

Comprehensive Exam:

Role of CD177 in Tumor-Infiltrating Regulatory T cells

Founded Cell Bioengines, LLC  

Selected Publications

PubMed

  1. Vishwakarma, A. and J. Karp (2017). Biology and Engineering of Stem Cell Niches, Elsevier.
  2. Vishwakaram, A, P. Sharpe, S. Shi, and M. Ramalingam. Stem Cell Biology and Tissue Engineering in Dental Sciences, Elsevier. 
  3. Sabree SA, Voigt AP, Blackwell SE, Vishwakarma A, Chimenti MS, et al.Direct and indirect immune effects of CMP-001, a virus-like particle containing a TLR9 agonist. J Immunother Cancer. 2021 Jun;9(6):e002484. 
  4. Kim MC, Borcherding N, Ahmed KK, Voigt AP, Vishwakarma A, et al.CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells. Nat Commun. 2021 Oct 1;12(1):5764.
Ajaykumar Vishwakarma
Education
MS, Cardiff University, UK; BDS, Maharashtra University of Health Sciences, India